Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06333171 · ClinicalTrials.gov registry record · Phase 2
4-aminopyridine for Skin Wound Healing
A Phase 2 study of Wounds and Injuries and Wound Heal, sponsored by John Elfar.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06333171 is a Phase 2 study of Wounds and Injuries and Wound Heal that is actively recruiting participants, run by John Elfar. The registered enrollment target is 150 participants, below the 498-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06333171, a Phase 2 study of Wounds and Injuries and Wound Heal, is actively recruiting participants, sponsored by John Elfar.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Many patients suffer from chronic non-healing wounds as well as acute wounds. There is a need to develop treatments to accelerate and improve healing of chronic and acute wounds. More research is needed to evaluate the role of 4-aminopyridine (4-AP), a promising new agent with an excellent safety profile, on wound healing. The investigational treatment will be used to evaluate the role of (4-AP) on the treatment of wounds to accelerate wound healing in healthy adults. The purpose of this study is to evaluate the role of 4-AP on the treatment of wounds to accelerate healing. The investigational treatment will be used to test the hypothesis that 4-AP can speed wound healing.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG 4-Aminopyridine
Study Locations (1)
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-09 |
| Est. Completion | 2028-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06333171
The ClinicalTrials.gov registry entry for NCT06333171 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 498-participant average among 27 other Wounds and Injuries trials with a reported enrollment target (70% lower). The listed sponsor is John Elfar, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Wounds and Injuries appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06333171 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT06333171 about?
NCT06333171 is a clinical study titled "4-aminopyridine for Skin Wound Healing". Many patients suffer from chronic non-healing wounds as well as acute wounds. There is a need to develop treatments to accelerate and improve healing of chronic and acute wounds. More research is needed to evaluate the role of 4-aminopyridine (4-AP), a promising new agent with an excellent safety pr...
What is the current status of trial NCT06333171?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2025-09. Estimated completion is 2028-03.
What conditions does trial NCT06333171 study?
This clinical trial studies the following conditions: Wounds and Injuries, Wound Heal, Wound of Skin, Wounds.
What interventions are being tested in trial NCT06333171?
The interventions under investigation include: Placebo (OTHER), 4-Aminopyridine (DRUG).
Who is sponsoring clinical trial NCT06333171?
This trial is sponsored by John Elfar, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06333171 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wounds and Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
4-Aminopyridine to Treat Skin Burns
RECRUITING · Phase 2
-
Human Penile Allotransplantation
RECRUITING · Phase 2
-
Human Upper Extremity Allotransplantation
RECRUITING · Phase 2
-
Feasibility Study for Fibroblast Autologous Skin Grafts
RECRUITING · Phase 2
-
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
RECRUITING · Phase 3
-
Effect of Giving Reduced Fluid in Children After Trauma
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.